United States Pseudomonas Aeruginosa Pneumonia Drug Market Report 2017

December 2017 | 100 pages | ID: UC0BBFF5B14EN
QYResearch

Abstracts

In this report, the United States Pseudomonas Aeruginosa Pneumonia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pseudomonas Aeruginosa Pneumonia Drug in these regions, from 2012 to 2022 (forecast).

United States Pseudomonas Aeruginosa Pneumonia Drug market competition by top manufacturers/players, with Pseudomonas Aeruginosa Pneumonia Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aridis Pharmaceuticals LLC
• Emergent BioSolutions Inc
• MedImmune LLC
• Polyphor Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Aerucin
• EV-035
• MEDI-3902
• Panobacumab
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pseudomonas Aeruginosa Pneumonia Drug Market Report 2017

1 PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG OVERVIEW

1.1 Product Overview and Scope of Pseudomonas Aeruginosa Pneumonia Drug
1.2 Classification of Pseudomonas Aeruginosa Pneumonia Drug by Product Category
  1.2.1 United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Aerucin
  1.2.4 EV-035
  1.2.5 MEDI-3902
  1.2.6 Panobacumab
  1.2.7 Others
1.3 United States Pseudomonas Aeruginosa Pneumonia Drug Market by Application/End Users
  1.3.1 United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Pseudomonas Aeruginosa Pneumonia Drug Market by Region
  1.4.1 United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
  1.4.5 New England Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
  1.4.6 The South Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Pseudomonas Aeruginosa Pneumonia Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pseudomonas Aeruginosa Pneumonia Drug (2012-2022)
  1.5.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pseudomonas Aeruginosa Pneumonia Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Pseudomonas Aeruginosa Pneumonia Drug Market Competitive Situation and Trends
  2.4.1 United States Pseudomonas Aeruginosa Pneumonia Drug Market Concentration Rate
  2.4.2 United States Pseudomonas Aeruginosa Pneumonia Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pseudomonas Aeruginosa Pneumonia Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales and Market Share by Region (2012-2017)
3.2 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Pseudomonas Aeruginosa Pneumonia Drug Price by Region (2012-2017)

4 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Pseudomonas Aeruginosa Pneumonia Drug Price by Type (2012-2017)
4.4 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales and Market Share by Application (2012-2017)
5.2 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aridis Pharmaceuticals LLC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pseudomonas Aeruginosa Pneumonia Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Emergent BioSolutions Inc
  6.2.2 Pseudomonas Aeruginosa Pneumonia Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 MedImmune LLC
  6.3.2 Pseudomonas Aeruginosa Pneumonia Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Polyphor Ltd
  6.4.2 Pseudomonas Aeruginosa Pneumonia Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG MANUFACTURING COST ANALYSIS

7.1 Pseudomonas Aeruginosa Pneumonia Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pseudomonas Aeruginosa Pneumonia Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pseudomonas Aeruginosa Pneumonia Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pseudomonas Aeruginosa Pneumonia Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PSEUDOMONAS AERUGINOSA PNEUMONIA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pseudomonas Aeruginosa Pneumonia Drug
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Aerucin Product Picture
Figure EV-035 Product Picture
Figure MEDI-3902 Product Picture
Figure Panobacumab Product Picture
Figure Others Product Picture
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Pseudomonas Aeruginosa Pneumonia Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Players/Suppliers
Figure 2017 United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Players/Suppliers
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Players/Suppliers
Figure 2017 United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Players/Suppliers
Table United States Market Pseudomonas Aeruginosa Pneumonia Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Pseudomonas Aeruginosa Pneumonia Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Share of Top 3 Players/Suppliers
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pseudomonas Aeruginosa Pneumonia Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pseudomonas Aeruginosa Pneumonia Drug Product Category
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs) by Region (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Region (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Region (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region in 2016
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Region (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region in 2016
Table United States Pseudomonas Aeruginosa Pneumonia Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs) by Type (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Type (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Type (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type in 2016
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pseudomonas Aeruginosa Pneumonia Drug by Type (2012-2017)
Figure Revenue Market Share of Pseudomonas Aeruginosa Pneumonia Drug by Type in 2016
Table United States Pseudomonas Aeruginosa Pneumonia Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate by Type (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs) by Application (2012-2017)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application in 2016
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate by Application (2012-2017)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate by Application (2012-2017)
Table Aridis Pharmaceuticals LLC Basic Information List
Table Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2012-2017)
Figure Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in United States (2012-2017)
Figure Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share in United States (2012-2017)
Table Emergent BioSolutions Inc Basic Information List
Table Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in United States (2012-2017)
Figure Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share in United States (2012-2017)
Table MedImmune LLC Basic Information List
Table MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2012-2017)
Figure MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in United States (2012-2017)
Figure MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share in United States (2012-2017)
Table Polyphor Ltd Basic Information List
Table Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2012-2017)
Figure Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share in United States (2012-2017)
Figure Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pseudomonas Aeruginosa Pneumonia Drug
Figure Manufacturing Process Analysis of Pseudomonas Aeruginosa Pneumonia Drug
Figure Pseudomonas Aeruginosa Pneumonia Drug Industrial Chain Analysis
Table Raw Materials Sources of Pseudomonas Aeruginosa Pneumonia Drug Major Players/Suppliers in 2016
Table Major Buyers of Pseudomonas Aeruginosa Pneumonia Drug
Table Distributors/Traders List
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pseudomonas Aeruginosa Pneumonia Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources